BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

951 related articles for article (PubMed ID: 26762744)

  • 21. Adrenomedullin 2 and 5 activate the calcitonin receptor-like receptor (clr) - Receptor activity-modifying protein 3 (ramp3) receptor complex in Xenopus tropicalis.
    Ogoshi M; Takahashi M; Aoyagi K; Ukena K; Aizawa S; Takeuchi H; Takahashi S; Takeuchi S
    Gen Comp Endocrinol; 2021 May; 306():113752. PubMed ID: 33711314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesothelin overexpression promotes mesothelioma cell invasion and MMP-9 secretion in an orthotopic mouse model and in epithelioid pleural mesothelioma patients.
    Servais EL; Colovos C; Rodriguez L; Bograd AJ; Nitadori J; Sima C; Rusch VW; Sadelain M; Adusumilli PS
    Clin Cancer Res; 2012 May; 18(9):2478-89. PubMed ID: 22371455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ligand-induced internalization, recycling, and resensitization of adrenomedullin receptors depend not on CLR or RAMP alone but on the receptor complex as a whole.
    Nag K; Sultana N; Kato A; Dranik A; Nakamura N; Kutsuzawa K; Hirose S; Akaike T
    Gen Comp Endocrinol; 2015 Feb; 212():156-62. PubMed ID: 24815888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma Cells.
    Rao M; Atay SM; Shukla V; Hong Y; Upham T; Ripley RT; Hong JA; Zhang M; Reardon E; Fetsch P; Miettinen M; Li X; Peer CJ; Sissung T; Figg WD; De Rienzo A; Bueno R; Schrump DS
    Clin Cancer Res; 2016 Mar; 22(5):1197-210. PubMed ID: 26459178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular effects of exogenous adrenomedullin and CGRP in Ramp and Calcrl deficient mice.
    Pawlak JB; Wetzel-Strong SE; Dunn MK; Caron KM
    Peptides; 2017 Feb; 88():1-7. PubMed ID: 27940069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and role of GLUT-1, MCT-1, and MCT-4 in malignant pleural mesothelioma.
    Mogi A; Koga K; Aoki M; Hamasaki M; Uesugi N; Iwasaki A; Shirakusa T; Tamura K; Nabeshima K
    Virchows Arch; 2013 Jan; 462(1):83-93. PubMed ID: 23187830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The third extracellular loop of the human calcitonin receptor-like receptor is crucial for the activation of adrenomedullin signalling.
    Kuwasako K; Hay DL; Nagata S; Hikosaka T; Kitamura K; Kato J
    Br J Pharmacol; 2012 May; 166(1):137-50. PubMed ID: 22142144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of Met/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma.
    Suzuki Y; Sakai K; Ueki J; Xu Q; Nakamura T; Shimada H; Nakamura T; Matsumoto K
    Int J Cancer; 2010 Oct; 127(8):1948-57. PubMed ID: 20104519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and distribution of the adrenomedullin system in newborn human thymus.
    De Martin S; Paliuri G; Belloni A; Orso G; Zanarella E; Stellin G; Milanesi O; Basso G; Ruga EM; Frasson C; Gabbia D; Perdoncin G; Palatini P; Bova S
    PLoS One; 2014; 9(5):e97592. PubMed ID: 24831942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of cardiovascular development and homeostasis by the adrenomedullin-RAMP system.
    Shindo T; Tanaka M; Kamiyoshi A; Ichikawa-Shindo Y; Kawate H; Yamauchi A; Sakurai T
    Peptides; 2019 Jan; 111():55-61. PubMed ID: 29689347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional differentiation of RAMP2 and RAMP3 in their regulation of the vascular system.
    Yamauchi A; Sakurai T; Kamiyoshi A; Ichikawa-Shindo Y; Kawate H; Igarashi K; Toriyama Y; Tanaka M; Liu T; Xian X; Imai A; Zhai L; Owa S; Arai T; Shindo T
    J Mol Cell Cardiol; 2014 Dec; 77():73-85. PubMed ID: 25264174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of cyclin-dependent kinase 7 down-regulates yes-associated protein expression in mesothelioma cells.
    Miao J; Kyoyama H; Liu L; Chan G; Wang Y; Urisman A; Yang YL; Liu S; Xu Z; Bin H; Li H; Jablons DM; You L
    J Cell Mol Med; 2020 Jan; 24(1):1087-1098. PubMed ID: 31755214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological characterisation of the mechanisms underlying the relaxant effect of adrenomedullin in the rat carotid artery.
    Passaglia P; Gonzaga NA; Tirapelli DP; Tirapelli LF; Tirapelli CR
    J Pharm Pharmacol; 2014 Dec; 66(12):1734-46. PubMed ID: 25117796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Ubiquitination and Hepatocyte Growth Factor-Regulated Tyrosine Kinase Substrate in the Degradation of the Adrenomedullin Type I Receptor.
    Roux BT; Bauer CC; McNeish AJ; Ward SG; Cottrell GS
    Sci Rep; 2017 Sep; 7(1):12389. PubMed ID: 28959041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma.
    Johnson TG; Schelch K; Cheng YY; Williams M; Sarun KH; Kirschner MB; Kao S; Linton A; Klebe S; McCaughan BC; Lin RCY; Pirker C; Berger W; Lasham A; van Zandwijk N; Reid G
    J Thorac Oncol; 2018 Feb; 13(2):258-272. PubMed ID: 29113949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Probing the Mechanism of Receptor Activity-Modifying Protein Modulation of GPCR Ligand Selectivity through Rational Design of Potent Adrenomedullin and Calcitonin Gene-Related Peptide Antagonists.
    Booe JM; Warner ML; Roehrkasse AM; Hay DL; Pioszak AA
    Mol Pharmacol; 2018 Apr; 93(4):355-367. PubMed ID: 29363552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-function analyses reveal a triple β-turn receptor-bound conformation of adrenomedullin 2/intermedin and enable peptide antagonist design.
    Roehrkasse AM; Booe JM; Lee SM; Warner ML; Pioszak AA
    J Biol Chem; 2018 Oct; 293(41):15840-15854. PubMed ID: 30139742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potentiated response to adrenomedullin in myocardia and aortas in spontaneously hypertensive rat.
    Pan ChS; Jiang W; Wu ShY; Zhao J; Pang YZ; Tang ChS; Qi YF
    Basic Res Cardiol; 2006 May; 101(3):193-203. PubMed ID: 16450076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma.
    Villanova T; Gesmundo I; Audrito V; Vitale N; Silvagno F; Musuraca C; Righi L; Libener R; Riganti C; Bironzo P; Deaglio S; Papotti M; Cai R; Sha W; Ghigo E; Schally AV; Granata R
    Proc Natl Acad Sci U S A; 2019 Feb; 116(6):2226-2231. PubMed ID: 30659154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of yes-associated protein down-regulates PD-L1 (CD274) expression in human malignant pleural mesothelioma.
    Hsu PC; Miao J; Wang YC; Zhang WQ; Yang YL; Wang CW; Yang CT; Huang Z; You J; Xu Z; Jablons DM; You L
    J Cell Mol Med; 2018 Jun; 22(6):3139-3148. PubMed ID: 29575535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.